Estadístiques de Immunomodulatory roles of PARP-1 and PARP-2: impact on PARP-centered cancer therapies
Visites totals
| views | |
|---|---|
| Immunomodulatory roles of PARP-1 and PARP-2: impact on PARP-centered cancer therapies | 140 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| yelamos-can-immu.pdf(legacy) | 96 |
| yelamos-can-immu.pdf | 36 |
Vistes principals per país
| views | |
|---|---|
| United States | 72 |
| Spain | 13 |
| Sweden | 12 |
| Canada | 8 |
| Germany | 4 |
| Italy | 4 |
| South Korea | 4 |
| France | 3 |
| Hungary | 3 |
| Belgium | 2 |
| Ireland | 2 |
| India | 2 |
| Australia | 1 |
| Finland | 1 |
| United Kingdom | 1 |
| Hong Kong SAR China | 1 |
| Japan | 1 |
| Malaysia | 1 |
| Romania | 1 |
| Slovakia | 1 |
| Turkey | 1 |
| Taiwan | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 10 |
| Redwood City | 7 |
| Ann Arbor | 6 |
| Edmonton | 6 |
| Menlo Park | 6 |
| Mountain View | 5 |
| Rome | 4 |
| Ashburn | 3 |
| Ashland | 3 |
| Boardman | 3 |
| Fairfield | 3 |
| Jackson | 3 |
| La Laguna | 3 |
| Palo Alto | 3 |
| San Francisco | 3 |
| Budakeszi | 2 |
| Granollers | 2 |
| San Diego | 2 |
| Tegueste | 2 |
| Agüimes | 1 |
| Alella | 1 |
| Almazora | 1 |
| Barcelona | 1 |
| Cambridge | 1 |
| Chungnam | 1 |
| Granada | 1 |
| Hong Kong | 1 |
| Istanbul | 1 |
| Kelowna | 1 |
| Kobe | 1 |
| Limerick | 1 |
| Los Angeles | 1 |
| Madrid | 1 |
| Mainz | 1 |
| Nottingham | 1 |
| Pinjarra | 1 |
| Pittsburgh | 1 |
| Popesti-leordeni | 1 |
| Saint Thomas | 1 |
| Seattle | 1 |
| Shah Alam | 1 |
| Siófok | 1 |
| Tampa | 1 |
| Tulsa | 1 |
| Waterford | 1 |